Guaifenesin
NDC Package 50090-4856-0

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Guaifenesin is follow dosage below or use as directed by a physician.•do not take more than 6 doses in any 24-hour periodagedoseadults and children 12 years and over10 to 20 mL (2 to 4 teaspoonfuls) every 4 hourschildren 6 years to under 12 years5 to 10 mL (1 to 2 teaspoonfuls) every 4 hourschildren 2 to under 6 years of age2.5 to 5 mL (1/2 to 1 teaspoonful) every 4 hourschildren under 2 years of ageask a doctorHow Supplied:Guaifenesin Oral Solution is a clear viscous liquid with a slight cherry odor supplied in the following oral dosage forms: 5 mL unit dose, 10 mL unit dose, 15 mL unit dose in trays of 10 and 4 fl. Marketed by A-s Medication Solutions, this product is identified by NDC 50090-4856 and is authorized under FDA application part341.

Identification & Billing

NDC Package Code
50090-4856-0
Package Description
10 CUP, UNIT-DOSE in 1 TRAY / 10 mL in 1 CUP, UNIT-DOSE
Product Code
50090-4856
11-Digit Billing Format
50090485600
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Guaifenesin
Dosage Form
-
Usage Information
Follow dosage below or use as directed by a physician.•do not take more than 6 doses in any 24-hour periodagedoseadults and children 12 years and over10 to 20 mL (2 to 4 teaspoonfuls) every 4 hourschildren 6 years to under 12 years5 to 10 mL (1 to 2 teaspoonfuls) every 4 hourschildren 2 to under 6 years of age2.5 to 5 mL (1/2 to 1 teaspoonful) every 4 hourschildren under 2 years of ageask a doctorHow Supplied:Guaifenesin Oral Solution is a clear viscous liquid with a slight cherry odor supplied in the following oral dosage forms: 5 mL unit dose, 10 mL unit dose, 15 mL unit dose in trays of 10 and 4 fl. oz. (118 mL) bottlePhenylketonurics: contains phenylalanine 8.4 mg per teaspoonful (5 mL)

Regulatory & Marketing

Labeler Name
A-s Medication Solutions
FDA Application #
part341
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
03-07-2012
Listing Expiration
12-31-2022
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 50090-4856-0 identifies a specific commercial package of 10 cup, unit-dose in 1 tray / 10 ml in 1 cup, unit-dose of Guaifenesin, labeled by A-s Medication Solutions. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by A-s Medication Solutions on March 07, 2012. The current certification is valid through December 31, 2022.

How is this A-s Medication Solutions product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 50090485600. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
50090-4856-0
11-Digit CMS (5-4-2)
50090-4856-00

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.